Understanding the Role of the 5-HT2B Receptor in Fibrosis with Special Focus on Systemic Sclerosis-ILD
Time: 5:00 pm
day: Day One
Details:
- Exploring the mechanism of action
- Using a variety of preclinical models to evaluate the therapeutic’s effectiveness
- Harnessing RNA sequencing to show target engagement in relevant cells
- Moving from Phase 1 into systemic sclerosis patients with focus on biomarkers
